Add like
Add dislike
Add to saved papers

Former professional football players may be at greater risk of chronic disease

2 Minute Medicine 2023 Februrary 8

1. In this retrospective cohort study, there was an increased prevalence of age-, race-, and body mass index (BMI)-adjusted cardiovascular, musculoskeletal, and neurodegenerative diseases in former professional American-style football (ASF) players compared to the general population.

2. Additionally, the proportion of individuals without any chronic diseases was lower in former ASF players compared to the general population.

Evidence Rating Level: 2 (Great)

Participation in American-style football (ASF) has been shown to have several health consequences. Participants have been noted to develop vascular, cognitive, endocrine, and neurological conditions following their playing years. However, the mechanisms underpinning these multiorgan repercussions are poorly understood. As a result, the objective of the present study was to investigate the impact of playing professional ASF on chronic disease burden.

Of 4174 individuals from the Football Players Health Study (FPHS), 2864 former ASF players ages 25-59 who played after 1960 were included in the study. The former players filled out a survey regarding playing career, demographics, and chronic disease. The general population cohort was taken from two surveys: the National Health and Nutrition Examination Survey (NHANES; n=1481) from 2015-2018 and the National Health Interview Survey (NHIS; n=6298) from 2019. Statistical analyses were performed using standardized prevalence rates for age, race, and body mass index. The primary outcome was the prevalence of chronic disease.

The results demonstrated that several chronic medical conditions including, arthritis and dementia/Alzheimer’s, were higher among former ASF players than the general population across all age groups. Furthermore, the prevalence of individuals with no chronic diseases was significantly lower among ASF players compared to the general population. However, the study was limited by self-reported data which may have introduced inaccurate reporting. Nonetheless, these results provide further evidence that participation in professional ASF may increase the risk of chronic disease in an individual’s future.

Click to read the study in British Journal of Sports Medicine

Originally Published By 2 Minute Medicine®. Reused on Read by QxMD with permission.

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Add to Saved Papers

Get 1-tap access

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app